28 March 2022 - Deborah Wilkes
Premium
Alliance Pharma has accessed the OTC scar treatment market in the US by acquiring the ScarAway brand and US rights to Kelo-cote from Perrigo for USD19.4 million in cash.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.